GU Cancers 2021 | Assessing the impact of the COVID-19 pandemic on patients with genitourinary cancer

Hala Borno, MD, BS, University of California San Francisco, San Francisco, CA, outlines the impact of the COVID-19 pandemic on patients with genitourinary malignancies and how this impact can be assessed. Dr Borno describes changes in patient behavior, economic circumstances and the introduction of telemedicine as a result of the COVID-19 pandemic, and predicts that these changes may have clinical implications on patient outcomes. This interview took place during the 2021 Genitourinary Cancers Symposium.